One day, they could support people at work or when walking, or replace injured muscle tissue. However, developing artificial ...

Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...

DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a ...

Find out the latest median prices, property market data & demographic info.